Search

everythinglearnresearchcommunity

for

Search:↓

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

GLP-1RA therapy may increase the risk of hair loss.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

More research is needed to understand if GLP-1 agonists affect hair health.

Potassium channel openers like minoxidil boost hair growth.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Provenge extends prostate cancer survival by about 4 months.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Neurosteroids may help treat disorders with too much dopamine activity.

PP405 shows promise as a new, effective treatment for hair loss with minimal side effects.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Researchers created a new mouse model, G4, that mimics human PCOS symptoms and links the condition to a specific gene.

Ganoderma lucidum may help treat enlarged prostate in rats.